Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Queen's University Belfast leads new research to better understand biology of prostate cancer

Queen's University Belfast leads new research to better understand biology of prostate cancer

Researchers reveal how certain nerves sustain prostate cancer growth

Researchers reveal how certain nerves sustain prostate cancer growth

New research provides insights into role of key cancer gene

New research provides insights into role of key cancer gene

New study describes unique role of androgens in kidney cancer

New study describes unique role of androgens in kidney cancer

Research finds higher rates of cancer in world's ‘better’ countries

Research finds higher rates of cancer in world's ‘better’ countries

Genetic signature within prostate cancer cells can predict metastatic tumors

Genetic signature within prostate cancer cells can predict metastatic tumors

UAlberta researchers create new imaging agents to keep track of tumor growth

UAlberta researchers create new imaging agents to keep track of tumor growth

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

New study reveals impact of Agent Orange exposure on women and babies in Vietnam

New study reveals impact of Agent Orange exposure on women and babies in Vietnam

Loyola Medicine physicians propose new system to improve reporting of robotic surgeries

Loyola Medicine physicians propose new system to improve reporting of robotic surgeries

UTSA professor awarded grant to support development of prostate cancer detection method

UTSA professor awarded grant to support development of prostate cancer detection method

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Research reveals sugary secrets of protein important for development and cancer progression

Research reveals sugary secrets of protein important for development and cancer progression

Fusion guided biopsy can help with accurate diagnosis of prostate cancer

Fusion guided biopsy can help with accurate diagnosis of prostate cancer

‘Nanoswitches’ could be key to faster, more sensitive tests for detection of biomarkers

‘Nanoswitches’ could be key to faster, more sensitive tests for detection of biomarkers

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Two new treatments may benefit patients with high risk prostate cancer, trial shows

Researchers reveal new approach to precisely identify and treat prostate cancer

Researchers reveal new approach to precisely identify and treat prostate cancer

New microfluidic device offers insights on cancer metastasis

New microfluidic device offers insights on cancer metastasis